Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus—A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial
用户sGjaISN0bR0M
59分钟前
9
10
求助中
帖子自动结束时间: 2026-10-06 23:56:13
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.2337/db18-3-LB
其他信息:
出版社: American Diabetes Association
作者: PARESH DANDONA; HUSAM GHANIM; NITESH D. KUHADIYA; TANVI SHAH; JEANNE M. HEJNA; ANTOINE MAKDISSI; MANAV BATRA; AJAY CHAUDHURI
全文下载地址: https://diabetesjournals.org/diabetes/article/67/Supplement_1/3-LB/57050/Liraglutide-as-an-Additional-Treatment-to-Insulin

